- Home
- INBX vs ESTA Comparison
INBX vs ESTA Comparison
Compare INBX & ESTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INBX | ESTA |
|---|---|---|
| Founded | 2010 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | 2024 | 2018 |
Fundamental Metrics
Financial Performance| Metric | INBX | ESTA |
|---|---|---|
| Price | $89.37 | $58.96 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | ★ $266.67 | $100.70 |
| AVG Volume (30 Days) | 207.0K | ★ 330.5K |
| Earning Date | 11-13-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 42.67 |
| EPS | N/A | ★ N/A |
| Revenue | $1,300,000.00 | ★ $61,208,000.00 |
| Revenue This Year | N/A | $28.00 |
| Revenue Next Year | N/A | $25.55 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 550.00 | 76.49 |
| 52 Week Low | $28.16 | $47.00 |
| 52 Week High | $155.29 | $97.59 |
Technical Indicators
Market Signals| Indicator | INBX | ESTA |
|---|---|---|
| Relative Strength Index (RSI) | 38.29 | 36.10 |
| Support Level | $85.65 | $53.16 |
| Resistance Level | $99.33 | $68.21 |
| Average True Range (ATR) | 4.70 | 3.24 |
| MACD | -0.79 | -0.11 |
| Stochastic Oscillator | 23.38 | 32.23 |
Price Performance
Historical ComparisonAbout INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About ESTA Establishment Labs Holdings Inc.
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.